查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
腦部健康補充品的全球市場:市場規模 - 各年齡層，各產品，各補充品形態，各用途，各銷售管道，各地區展望，競爭策略，各市場區隔預測(～2032年)
市場調查報告書
商品編碼
1170430

腦部健康補充品的全球市場:市場規模 - 各年齡層，各產品，各補充品形態，各用途，各銷售管道，各地區展望，競爭策略，各市場區隔預測(～2032年)

Brain Health Supplements Market Size- By Age Group, By Product, By Supplement Form, By Application, By Sales Channel- Regional Outlook, Competitive Strategies and Segment Forecasts to 2032
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球腦部健康補充品的市場規模，預計至2032年達到174億1,000萬美元，以8.53％的年複合成長率成長。

由於人們的心理和情緒健康狀況下降，COVID-19流行病對市場產生積極影響並增加消費者需求。隨著第二波COVID-19促使消費者在日常生活中服用膳食補充劑以保護自己免受嚴重呼吸系統綜合症的侵害，對大腦健康補充劑的需求顯著增加。

本報告提供全球腦部健康補充品市場相關調查，市場動態，市場變數與展望，各年齡層、產品、補充品形態、用途、銷售管道、地區的市場分析，企業簡介等相關資訊。

目錄

第1章 簡介

  • 調查範圍
  • 市場區隔分析

第2章 調查手法

  • 調查資料來源
  • 市場規模的估計
  • 資料的三角測量

第3章 摘要整理

第4章 市場動態

  • 促進因素，阻礙因素，機會，課題的分析
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題
  • 全球腦部健康補充品市場上COVID-19的影響

第5章 市場變數與展望

  • SWOT分析
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • PESTEL分析
    • 政治形勢
    • 經濟形勢
    • 社會形勢
    • 技術形勢
    • 環境形勢
    • 法律上的形勢
  • 波特的五力分析
    • 供給企業談判力
    • 買方議價能力
    • 替代品的威脅
    • 新加入廠商的威脅
    • 競爭企業間的敵對關係
  • 熱圖分析

第6章 全球腦部健康補充品市場:各年齡層(2019年～2032年(100萬美元))

  • 成人
  • 老年人
  • 兒童

第7章 全球腦部健康補充品市場:各產品(2019年～2032年(100萬美元))

  • 藥草萃取物
    • 過長沙
    • 薑黃素
    • 銀杏
    • 高麗人參
    • 猴頭菇
    • 其他
  • 維生素和礦物質
    • 維他命B
    • 維他命C、E
    • 其他
  • 天然分子
    • Acetyle-i-carnitine
    • Alphagpc
    • 胞磷膽鹼
    • 二十二碳六烯酸
    • Huperzine A
    • 其他

第8章 全球腦部健康補充品市場:各補充品形態(2019年～2032年(100萬美元))

  • 膠囊
  • 錠劑
  • 其他

第9章 全球腦部健康補充品市場:各用途(2019年～2032年(100萬美元))

  • 不安
  • 注意力、集中力
  • 長壽、抗老化
  • 記憶力增強
  • 心情、憂鬱症
  • 睡眠、復甦

第10章 全球腦部健康補充品市場:各銷售管道(2019年～2032年(100萬美元))

  • 藥局
  • 網路商店
  • 超級市場、大賣場
  • 其他

第11章 全球腦部健康補充品市場:各地區(2019年～2032年(100萬美元))

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他的亞太地區
  • 南美
    • 巴西
    • 阿根廷
    • 其他的南美
  • 中東、非洲
    • 沙烏地阿拉伯王國
    • 阿拉伯聯合大公國
    • 其他的中東、非洲

第12章 企業簡介

  • Adisseo
    • 企業概要
    • 財務展望
    • 產品概要
    • 最近的開發
  • ADM
  • AlternaScript
  • BASF SE
  • BTSA Biotechnologias Aplicadas S.L.
  • DSM
  • Farbest Brands
  • Glanbia PLC
  • HVMN Inc.
  • Intelligent Labs
  • Lonza Group
  • Natural Factors Nutritional Product Ltd.
  • NOW Foods
  • Onnit Labs Inc.
  • Peak Nootropics
  • Purelife Bioscience Co. Ltd.
  • Rabar Pty Ltd.
  • Reckitt Benckiser Group PLC
  • SternVitamin GmbH & Co. KG
  • Teva Pharmaceutical Ltd.
簡介目錄
Product Code: PHAR2212

Global Brain Health Supplements Market Overview:

According to SPER Market Research, the Global Brain Health Supplements Market is estimated to reach USD 17.41 billion by 2032 with a CAGR of 8.53%.

Natural substances found in brain health supplements have advantageous impacts on the brain. These dietary supplements, which come in the form of herbal extracts in capsules, pills, and powders, assist healthy individuals in enhancing their memory, creativity, attention, motivation, and alertness. It has been demonstrated that herbs like withania somnifera and bacopa monniera enhance brain function. Additionally, B and C vitamins are good for the functioning of the nerves and brain. Supplements are goods that are utilised to correct and strengthen any kind of physical deficiencies in people. Supplements are available to consumers as tablets, capsules, soft gels, powders, or liquids. The type of supplements, such as herbal supplements and natural supplements, can be used to categorise them.

Impact of COVID-19 on the Global Brain Health Supplements Market:

Due to people's declining mental and emotional health, the COVID-19 epidemic has had a favorable effect on the market and increased consumer demand for these items. Due to the uncertainties surrounding the ongoing COVID-19 lawsuits around the world, people are spending more money on products that support memory. The epidemic has caused a disruption in the supply chain, affecting both the supply of finished goods and the acquisition of raw materials. The production of supplements has been somewhat impeded as a result of the bans that several nations have placed on the import and export of raw materials. The demand for brain health supplements has significantly increased as a result of the coronavirus 2nd wave, which has motivated consumers to consume dietary supplements in their everyday lives to protect themselves from severe respiratory syndrome coronavirus.

Scope of the Report:

Report Metric Details:

  • Market size available for years: 2019-2032
  • Base year considered: 2021
  • Forecast period: 2022-2032
  • Segments covered: By Age Group, By Product, By Supplement Form, By Application, By Sales Channel
  • Regions covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa
  • Companies Covered: Adisseo, ADM, AlternaScript, BASF SE, BTSA Biotechnologias Aplicadas S.L., DSM, Farbest Brands, Glanbia PLC, HVMN Inc., Intelligent Labs, Lonza Group, Natural Factors Nutritional Products Ltd., NOW Foods, Onnit Labs, Inc., Peak Nootropics, Purelife Bioscience Co., Ltd., Rabar Pty Ltd., Reckitt Benckiser Group PLC., SternVitamin GmbH & Co. KG, Teva Pharmaceutical Industries Ltd

Global Brain Health Supplements Market Segmentation:

  • By Age Group: Based on the Age Group, Global Brain Health Supplements Market is segmented as; Adults, Elderly and Kids.
  • By Product: Based on the Product, Global Brain Health Supplements Market is segmented as; Herbal Extracts (Bacopa monnieri, Curcumin, Ginkgo bilola, Ginseng, Lions mane, Others), Vitamins and Minerals (Vitamin B, Vitamin C & E, Others), Natural Molecules (Acetyle-i-carnitine, Alpha gpc, Citicoline, Docosahexaenoic acid, Huperzine A, others).
  • By Supplement Form: Based on the Supplement Form, Global Brain Health Supplements Market is segmented as; Capsules, Tablets and Others.
  • By Application: Based on the Application, Global Brain Health Supplements Market is segmented as; Anxiety, Attention and Focus, Longevity and Anti-aging, Memory Enhancement, Mood and Depression, Sleep and Recovery.
  • By Sales Channel: Based on the Sales Channel, Global Brain Health Supplements Market is segmented as; Drug Stores, Online Stores, Supermarkets and Hypermarkets and Others.
  • By Region: In recent years, North America has contributed the most to the market. The demand for the product in North America is being driven by consumers' increased concerns about their mental health. Adults in the United States regularly use nutritional supplements containing vitamins, minerals, and botanical components to boost their performance, energy, and mental clarity. These trends are probably going to accelerate the market expansion in the nation. According to the American Psychological Association, loneliness and uncertainty about the future are significant stressors for adolescents and young adults in America. As a result, it is anticipated that more and more adults will take supplements for brain health in order to maintain proper brain function.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Brain Health Supplements Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Brain Health Supplements Market, By Age Group, 2019-2032 (USD Million)

  • 6.1. Adults
  • 6.2. Elderly
  • 6.3. Kids

7. Global Brain Health Supplements Market, By Product, 2019-2032 (USD Million)

  • 7.1. Herbal Extracts
    • 7.1.1. Bacopa monnieri
    • 7.1.2. Curcumin
    • 7.1.3. Ginkgo bilola
    • 7.1.4. Ginseng
    • 7.1.5. Lions mane
    • 7.1.6. Others
  • 7.2. Vitamins and Minerals
    • 7.2.1 Vitamin B
    • 7.2.2 Vitamin C & E
    • 7.2.3 Others
  • 7.3. Natural Molecules
    • 7.3.1 Acetyle-i-carnitine
    • 7.3.2 Alpha gpc
    • 7.3.3 Citicoline
    • 7.3.4 Docosahexaenoic acid
    • 7.3.5 Huperzine A
    • 7.3.6 others

8. Global Brain Health Supplements Market, By Supplement Form, 2019-2032 (USD Million)

  • 8.1. Capsules
  • 8.2. Tablets
  • 8.3. Others

9. Global Brain Health Supplements Market, By Application, 2019-2032 (USD Million)

  • 9.1. Anxiety
  • 9.2. Attention and Focus
  • 9.3. Longevity and Anti-aging
  • 9.4. Memory Enhancement
  • 9.5. Mood and Depression
  • 9.6. Sleep and Recovery

10. Global Brain Health Supplements Market, By Sales Channel, 2019-2032 (USD Million)

  • 10.1 Drug Stores
  • 10.2 Online Stores
  • 10.3 Others
  • 10.4 Supermarkets and Hypermarkets

11. Global Brain Health Supplements Market, By Region, 2019-2032 (USD Million)

  • 11.1 North America
    • 11.1.1. United States
    • 11.1.2. Canada
    • 11.1.3. Mexico
  • 11.2 Europe
    • 11.2.1. Germany
    • 11.2.2. United Kingdom
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3 Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4 South America
    • 11.4.1. Brazil
    • 11.4.2. Argentina
    • 11.4.3. Rest of South America
  • 11.5 Middle East & Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Rest of Middle East & Africa

12. Company Profiles

  • 12.1 Adisseo
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2 ADM
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3 AlternaScript
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4 BASF SE
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5 BTSA Biotechnologias Aplicadas S.L.
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6 DSM
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7 Farbest Brands
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8 Glanbia PLC
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9 HVMN Inc.
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10 Intelligent Labs
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11 Lonza Group
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary
    • 12.11.4. Recent developments
  • 12.12 Natural Factors Nutritional Product Ltd.
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary
    • 12.12.4. Recent developments
  • 12.13 NOW Foods
    • 12.13.1. Company details
    • 12.13.2. Financial outlook
    • 12.13.3. Product summary
    • 12.13.4. Recent developments
  • 12.14 Onnit Labs Inc.
    • 12.14.1. Company details
    • 12.14.2. Financial outlook
    • 12.14.3. Product summary
    • 12.14.4. Recent developments
  • 12.15 Peak Nootropics
    • 12.15.1. Company details
    • 12.15.2. Financial outlook
    • 12.15.3. Product summary
    • 12.15.4. Recent developments
  • 12.16 Purelife Bioscience Co. Ltd.
    • 12.16.1. Company details
    • 12.16.2. Financial outlook
    • 12.16.3. Product summary
    • 12.16.4. Recent developments
  • 12.17 Rabar Pty Ltd.
    • 12.17.1. Company details
    • 12.17.2. Financial outlook
    • 12.17.3. Product summary
    • 12.17.4. Recent developments
  • 12.18 Reckitt Benckiser Group PLC
    • 12.18.1. Company details
    • 12.18.2. Financial outlook
    • 12.18.3. Product summary
    • 12.18.4. Recent developments
  • 12.19 SternVitamin GmbH & Co. KG
    • 12.19.1. Company details
    • 12.19.2. Financial outlook
    • 12.19.3. Product summary
    • 12.19.4. Recent developments
  • 12.20 Teva Pharmaceutical Ltd.
    • 12.20.1. Company details
    • 12.20.2. Financial outlook
    • 12.20.3. Product summary
    • 12.20.4. Recent developments